Skip to main content
Aurobindo Pharma Limited (NSE:AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,121.00
-2.20 (-0.20%)
Jun 27, 2025, 3:30 PM IST

Aurobindo Pharma Revenue

In the fiscal year ending March 31, 2025, Aurobindo Pharma had annual revenue of 317.24B INR with 9.39% growth. Aurobindo Pharma had revenue of 83.82B in the quarter ending March 31, 2025, with 10.58% growth.

Revenue
317.24B
Revenue Growth
+9.39%
P/S Ratio
2.02
Revenue / Employee
12.19M
Employees
26,015
Market Cap
641.96B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025317.24B27.22B9.39%
Mar 31, 2024290.02B41.46B16.68%
Mar 31, 2023248.55B14.00B5.97%
Mar 31, 2022234.55B-13.19B-5.32%
Mar 31, 2021247.75B16.76B7.26%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 525.78B
Divi's Laboratories 93.60B
Cipla 272.67B
Apollo Hospitals Enterprise 217.94B
Zydus Lifesciences 232.42B
Mankind Pharma 122.07B
Fortis Healthcare 77.83B
Alkem Laboratories 129.65B
Revenue Rankings

Aurobindo Pharma News

More News